http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers in the development of chemo resistance in bladder cancer. http://medicalxpress.com/news/2013-03-epigenetic-key-role-chemo-resistance.html Cancer Mon, 18 Mar 2013 10:00:02 EST news282818485 New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results also suggest that certain patients with intermediate-risk disease can receive less aggressive adjuvant treatment, or perhaps forego it altogether. Avoiding chemotherapy spares patients from treatment side effects and long-term health risks, such as cardiovascular disease and development of a second cancer. http://medicalxpress.com/news/2013-03-prospective-children-retinoblastoma-safely-adjuvant.html Cancer Mon, 04 Mar 2013 16:00:03 EST news281624036 By all accounts, a combination of colon cancer, diabetes and high blood pressure can be a recipe for medical disaster. Now, a new study led by a surgical oncologist and researcher at Temple University School of Medicine and Fox Chase Cancer Center has shown just how deadly this mix can be. In a retrospective analysis of more than 36,000 patients with colon cancer, investigators showed that those with early stage disease and diabetes or high blood pressure – two components of metabolic syndrome – have a greater risk for the cancer returning after treatment and of dying compared to patients with colon cancer who do not have either condition. http://medicalxpress.com/news/2012-12-diabetes-blood-pressure-link-colon.html Cancer Thu, 20 Dec 2012 00:20:01 EST news275164075 (HealthDay)—For patients with stage 2 to 3 colon cancer, the addition of bevacizumab to modified fluorouracil, leucovorin, and oxaliplatin (FOLFOX6) does not prolong disease-free or overall survival, according to a study published online Dec. 10 in the Journal of Clinical Oncology. http://medicalxpress.com/news/2012-12-bevacizumab-doesnt-prolong-survival-stage.html Cancer Wed, 12 Dec 2012 04:54:48 EST news274510470 (HealthDay)—In women with breast cancer that has recurred but remains confined to in or near the breast, post-surgical chemotherapy appears to boost survival, new research shows. http://medicalxpress.com/news/2012-12-chemo-survival-breast-cancer.html Cancer Thu, 06 Dec 2012 16:20:01 EST news274030481 Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin), Yale School of Medicine researchers report in the current issue of the Journal of the American College of Cardiology. http://medicalxpress.com/news/2012-11-heart-failure-older-breast-cancer.html Cardiology Wed, 14 Nov 2012 15:30:01 EST news272129356 (HealthDay) -- For women with breast cancer, disease characteristics correlate significantly with chemotherapy receipt, with no indication of racial barriers to treatment, according to a study published online Aug. 6 in the Journal of Clinical Oncology. http://medicalxpress.com/news/2012-08-links-age-chemo.html Cancer Fri, 10 Aug 2012 05:40:01 EST news263794619 (HealthDay) -- Adjuvant chemotherapy for early-stage breast cancer can induce weight gain and a variety of metabolic changes that may be associated with a poor prognosis for some patients, according to research published in the April issue of Obesity Reviews. http://medicalxpress.com/news/2012-03-chemo-linked-factors-impact-weight-breast.html Cancer Thu, 29 Mar 2012 15:00:01 EST news252245930 (HealthDay) -- The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17 percent, and is associated with less advanced disease and higher functional status, according to a study published online Feb. 22 in Cancer. http://medicalxpress.com/news/2012-03-complementary-meds-percent-elderly-cancer.html Cancer Fri, 02 Mar 2012 12:42:01 EST news249914514 Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. http://medicalxpress.com/news/2011-12-obesity-linked-worse-outcomes-early.html Cancer Thu, 08 Dec 2011 04:40:02 EST news242539870 Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July 20 issue of JAMA. http://medicalxpress.com/news/2011-07-therapy-chemotherapy-induced-early-menopause-women.html Cancer Tue, 19 Jul 2011 16:51:27 EST news230313077 Additional radiation treatment improves disease free survival lessening the chance of cancer recurring in women with early breast cancer who have had breast conserving surgery (lumpectomy), interim results of a new study found. The results will be presented Monday, June 6, 2011 at the annual meeting of the American Society of Clinical Oncology. http://medicalxpress.com/news/2011-06-breast-cancer-surgery-patients-benefit.html Cancer Sat, 04 Jun 2011 13:24:25 EST news226412639